Suppression by Δ(9)-tetrahydrocannabinol of the Primary Immunoglobulin M Response by Human Peripheral Blood B Cells is Associated with Impaired STAT3 Activation

Overview

Journal Toxicology

Publisher Elsevier

Specialty Toxicology

Date 2013 Jun 4

PMID 23727458

Citations 6

Authors

Thitirat Ngaotepprutaram

Barbara L F Kaplan

Stephen Carney

Robert Crawford

Norbert E Kaminski

Affiliations

Soon will be listed here.

Abstract

This study was undertaken to gain insights into the mechanism for Δ(9)-tetrahydrocannabinol (Δ(9)-THC)-mediated suppression of primary immunoglobulin M (IgM) responses in humans. An in vitro activation model, which employs cell surface-expressed CD40 ligand (CD40L) and recombinant cytokines (interleukin (IL)-2, -6, and -10), was used to differentiate human peripheral blood (HPB) naïve B cells into IgM secreting cells. Pretreatment with Δ(9)-THC significantly decreased the number of IgM secreting cells as determined by ELISPOT. The attenuation of IgM secretion by Δ(9)-THC involved, at least in part, the impairment of plasma cell differentiation as evidenced by suppression of immunoglobulin joining chain (IgJ) mRNA expression. The analysis at each of two different stages critically involved in plasma cell differentiation indicates that Δ(9)-THC impaired both the primary activation stage and proliferation of B cells. Interestingly, Δ(9)-THC selectively suppressed the surface expression of CD80, but not other measured B-cell activation markers (CD69, CD86, and ICAM1). Furthermore, pretreatment with Δ(9)-THC was accompanied by a robust decrease of STAT3 phosphorylation, whereas the phosphorylation of the p65 NFκB subunit was not affected. Collectively, these data provide new insights into the mechanisms for impaired B cell function by Δ(9)-THC.

Citing Articles

Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection.

Hassan Kalantar Neyestanaki M, Gholizadeh O, Hosseini Tabatabaie F, Akbarzadeh S, Yasamineh S, Afkhami H Virusdisease. 2024; 35(2):342-356.

PMID: 39071880 PMC: 11269557. DOI: 10.1007/s13337-024-00871-0.

Cannabinoid Mixture Affects the Fate and Functions of B Cells through the Modulation of the Caspase and MAP Kinase Pathways.

Lampron M, Pare I, Al-Zharani M, Semlali A, Loubaki L Cells. 2023; 12(4).

PMID: 36831255 PMC: 9954265. DOI: 10.3390/cells12040588.

Impact of Δ-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells.

Lowin T, Kok C, Smutny S, Pongratz G Biomedicines. 2022; 10(5).

PMID: 35625855 PMC: 9138512. DOI: 10.3390/biomedicines10051118.

Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens.

Gu Z, Singh S, Niyogi R, Lamont G, Wang H, Lamont R Front Immunol. 2019; 10:2288.

PMID: 31681262 PMC: 6804395. DOI: 10.3389/fimmu.2019.02288.

miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Kumar V, Mansfield J, Fan R, MacLean A, Li J, Mohan M J Immunol. 2018; 200(8):2677-2689.

PMID: 29514950 PMC: 5893401. DOI: 10.4049/jimmunol.1701148.

References

Schatz A, Koh W, Kaminski N . Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology. 1993; 26(2):129-37. DOI: 10.1016/0162-3109(93)90005-b. View

Hodgkin P, Lee J, Lyons A . B cell differentiation and isotype switching is related to division cycle number. J Exp Med. 1996; 184(1):277-81. PMC: 2192686. DOI: 10.1084/jem.184.1.277. View

Faris M, Kokot N, Stahl N, Nel A . Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line. Immunology. 1997; 90(3):350-7. PMC: 1456618. DOI: 10.1111/j.1365-2567.1997.00350.x. View

Grotenhermen F . Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003; 42(4):327-60. DOI: 10.2165/00003088-200342040-00003. View

Collins A, Brodie D, Gilbert R, Iaboni A, Manso-Sancho R, Walse B . The interaction properties of costimulatory molecules revisited. Immunity. 2002; 17(2):201-10. DOI: 10.1016/s1074-7613(02)00362-x. View

Agudelo M, Newton C, Widen R, Sherwood T, Nong L, Friedman H . Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes. J Neuroimmune Pharmacol. 2008; 3(1):35-42. PMC: 2423231. DOI: 10.1007/s11481-007-9088-9. View

Avery D, Deenick E, Ma C, Suryani S, Simpson N, Chew G . B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med. 2010; 207(1):155-71. PMC: 2812540. DOI: 10.1084/jem.20091706. View

Lopez-Cabrera M, Munoz E, Blazquez M, Ursa M, Santis A, Sanchez-Madrid F . Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J Biol Chem. 1995; 270(37):21545-51. DOI: 10.1074/jbc.270.37.21545. View

HERRING A, Kaminski N . Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes. J Pharmacol Exp Ther. 1999; 291(3):1156-63. View

10.

Zou G, Hu W . LIGHT regulates CD86 expression on dendritic cells through NF-kappaB, but not JNK/AP-1 signal transduction pathway. J Cell Physiol. 2005; 205(3):437-43. DOI: 10.1002/jcp.20420. View

11.

Good-Jacobson K, Song E, Anderson S, Sharpe A, Shlomchik M . CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. J Immunol. 2012; 188(9):4217-25. PMC: 3331930. DOI: 10.4049/jimmunol.1102885. View

12.

Ahmadi T, Flies A, Efebera Y, Sherr D . CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides. Immunology. 2007; 124(1):129-40. PMC: 2434387. DOI: 10.1111/j.1365-2567.2007.02749.x. View

13.

Diehl S, Schmidlin H, Nagasawa M, van Haren S, Kwakkenbos M, Yasuda E . STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol. 2008; 180(7):4805-15. PMC: 2396731. DOI: 10.4049/jimmunol.180.7.4805. View

14.

Lamson G, Koshland M . Changes in J chain and mu chain RNA expression as a function of B cell differentiation. J Exp Med. 1984; 160(3):877-92. PMC: 2187408. DOI: 10.1084/jem.160.3.877. View

15.

Alinikula J, Lassila O . Gene interaction network regulates plasma cell differentiation. Scand J Immunol. 2011; 73(6):512-9. DOI: 10.1111/j.1365-3083.2011.02556.x. View

16.

Lu H, Crawford R, Kaplan B, Kaminski N . 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells. Toxicol Appl Pharmacol. 2011; 255(3):251-60. PMC: 3189629. DOI: 10.1016/j.taap.2011.06.026. View

17.

Tangye S, Avery D, Hodgkin P . A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol. 2002; 170(1):261-9. DOI: 10.4049/jimmunol.170.1.261. View

18.

Otero D, Poli V, David M, Rickert R . Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3. J Immunol. 2006; 177(10):6593-7. PMC: 2770730. DOI: 10.4049/jimmunol.177.10.6593. View

19.

Corcoran K, Jabbour M, Bhagwandin C, Deymier M, Theisen D, Lybarger L . Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). J Biol Chem. 2011; 286(43):37168-80. PMC: 3199464. DOI: 10.1074/jbc.M110.204040. View

20.

Lu H, Crawford R, North C, Kaplan B, Kaminski N . Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells. Toxicol Sci. 2009; 112(2):363-73. PMC: 2777081. DOI: 10.1093/toxsci/kfp224. View